Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage
Authors:
- Riccardo VagoRiccardo Vago
- Alessandro RavelliARAlessandro Ravelli
- Arianna BettigaABArianna Bettiga
- Silvana CasatiSCSilvana Casati
- Giovanni LavorgnaGLGiovanni Lavorgna
- Fabio BenigniFBFabio Benigni
- Andrea SaloniaASAndrea Salonia
- Francesco MontorsiFMFrancesco Montorsi
- Marica OrioliMarica Orioli
- Pierangela CiuffredaPierangela Ciuffreda
- Roberta OttriaRORoberta Ottria
Open Access
Abstract
Due to the involvement of the endocannabinoid system (ECS) in cancer onset and progression and the less studied connection between ECS and bladder cancer, here an evaluation of the ECS modifications associated with bladder cancer is reported. Urine samples were collected from healthy volunteers and patients with bladder cancer at different grades. Endocannabinoids (ECs) and N-acylethanolamides (NAEs) were quantified by HPLC-MS/MS and results normalized for creatinine content. An increase in the urine concentrations of four ECs and NAEs analyzed was observed with a statistically significant increase in the arachidonoylethanolamide (AEA) and stearoylethanoamide (SEA) associated with bladder cancer. Receiver operating characteristic curves built with AEA and SEA data allowed the selection of 160 pg/mL for SEA (area under the curve (AUC) = 0.91, Selectivity (SE) 94%, Specificity (SP) 45%) and 8 pg/mL for AEA (AUC = 0.85, SE 94%, SP 61%) as the best cut-off values. Moreover, data from bladder cancer samples at different grades were derived from The Cancer Genome Atlas, and the expressions of thirteen different components of the “endocannabinoidome” were analyzed. Statistical analysis highlights significant variations in the expression of three enzymes involved in EC and NAE turnover in bladder cancer.Keywords
This publication has 35 references indexed in Scilit:
- Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunctionNeurourology and Urodynamics, 2013
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortalScience Signaling, 2013
- Endogenous cannabinoids revisited: A biochemistry perspectiveProstaglandins & Other Lipid Mediators, 2013
- 1H, 13C and 15N NMR assignments for N‐ and O‐acylethanolamines, important family of naturally occurring bioactive lipid mediatorsMagnetic Resonance in Chemistry, 2012
- Distribution and function of the endocannabinoid system in the rat and human bladderInternational Urogynecology Journal, 2012
- Optimized synthesis and characterization of N-acylethanolamines and O-acylethanolamines, important family of lipid-signalling moleculesChemistry and Physics of Lipids, 2012
- Cannabinoids, endocannabinoids, and cancerCancer and Metastasis Reviews, 2011
- 1H, 13C and 15N NMR spectral assignments of adenosine derivatives with different amino substituents at C6‐positionMagnetic Resonance in Chemistry, 2011
- Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1Gynecologic Oncology, 2004
- Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cellsBiochemical Journal, 2002